Literature DB >> 17891522

Direct protective effects of poly-unsaturated fatty acids, DHA and EPA, against activation of cardiac late sodium current: a mechanism for ischemia selectivity.

Christophe Pignier1, Coralie Revenaz, Isabelle Rauly-Lestienne, Didier Cussac, André Delhon, Jean Gardette, Bruno Le Grand.   

Abstract

Polyunsaturated fatty acids (PUFAs) such as docosahexaenoic and eicosapentaenoic acids (DHA, EPA) exert ischemic anti-arrhythmic effects. However, their mechanism of action remains unknown. The present study was designed to investigate their potential effect on the regulation of the late sodium current as the basis for their ischemic anti-arrhythmic activity. Human isoforms of wild-type SCN5A and DeltaKPQ-mutated cardiac sodium channels were stably transfected in HEK 293 cells and, the resulting currents were recorded using the patch clamp technique in whole cell configuration. In addition to their effect to inhibit peak I(Na), acute application of DHA and EPA blocked veratridine-induced late sodium current (late I(Na-Verat)) in a concentration--dependent manner with IC(50) values of 2.1 +/- 0.5 microM and 5.2 +/- 0.8 microM,for DHA and EPA, respectively. Channels availability was reduced, resulting in a significant leftward shift of the steadystate inactivation curve by -10.0 +/- 2.1 mV and -8.5 +/- 0.2 mV for DHA and EPA, respectively. Similar inhibitory effects of DHA and EPA were also observed on late I(Na-KPQ). In addition to their role as blocking agents of peak I(Na), DHA and EPA reduced human late I(Na). These results could explain the antiarrhythmic properties of DHA and EPA during ischemia or following ischemia-reperfusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891522     DOI: 10.1007/s00395-007-0676-x

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  17 in total

1.  F 15845 inhibits persistent sodium current in the heart and prevents angina in animal models.

Authors:  B Vacher; C Pignier; R Létienne; Y Verscheure; B Le Grand
Journal:  Br J Pharmacol       Date:  2009-01-07       Impact factor: 8.739

2.  Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury.

Authors:  Hongjian Pu; Yanling Guo; Wenting Zhang; Lanting Huang; Guohua Wang; Anthony K Liou; Jia Zhang; Pengyue Zhang; Rehana K Leak; Yun Wang; Jun Chen; Yanqin Gao
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-26       Impact factor: 6.200

3.  Augmented bioavailability of felodipine through an α-linolenic acid-based microemulsion.

Authors:  Mahendra Singh; Jovita Kanoujia; Poonam Parashar; Malti Arya; Chandra B Tripathi; V R Sinha; Shailendra K Saraf; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

4.  Eicosapentaenoic acid attenuated oxidative stress-induced cardiomyoblast apoptosis by activating adaptive autophagy.

Authors:  Hsiu-Ching Hsu; Ching-Yi Chen; Chun-Hsien Chiang; Ming-Fong Chen
Journal:  Eur J Nutr       Date:  2013-07-26       Impact factor: 5.614

5.  17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues.

Authors:  John R Falck; Gerd Wallukat; Narender Puli; Mohan Goli; Cosima Arnold; Anne Konkel; Michael Rothe; Robert Fischer; Dominik N Müller; Wolf-Hagen Schunck
Journal:  J Med Chem       Date:  2011-06-01       Impact factor: 7.446

Review 6.  Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia.

Authors:  Sheridan M Hoy; Gillian M Keating
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

7.  Suppression of PPARβ, and DHA treatment, inhibit NaV1.5 and NHE-1 pro-invasive activities.

Authors:  Ramez Wannous; Emeline Bon; Ludovic Gillet; Julie Chamouton; Günther Weber; Lucie Brisson; Jacques Goré; Philippe Bougnoux; Pierre Besson; Sébastien Roger; Stephan Chevalier
Journal:  Pflugers Arch       Date:  2014-07-15       Impact factor: 3.657

8.  F 16915 prevents heart failure-induced atrial fibrillation: a promising new drug as upstream therapy.

Authors:  Bruno Le Grand; Robert Letienne; Elisabeth Dupont-Passelaigue; Frédérique Lantoine-Adam; Frédéric Longo; Monique David-Dufilho; Georghia Michael; Kunihiro Nishida; Daniel Catheline; Philippe Legrand; Stéphane Hatem; Stanley Nattel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-04-11       Impact factor: 3.000

9.  Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus.

Authors:  Kayode J Bello; Hong Fang; Parastoo Fazeli; Waleed Bolad; Mary Corretti; Laurence S Magder; Michelle Petri
Journal:  Rheumatol Int       Date:  2013-07-02       Impact factor: 2.631

Review 10.  Impact of dietary fatty acids on cardiac arrhythmogenesis.

Authors:  Julie H Rennison; David R Van Wagoner
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.